LG Chem and OTR Therapeutics announce a strategic collaboration to leverage China's life science ecosystem for oncology R&D.
2 reports, 1 independent
Updated Jul 7
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LG Chem and OTR Therapeutics announce a strategic collaboration to leverage China's life science ecosystem for oncology R&D.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Chinese biopharma is gaining ground, producing oncology drugs that rival established Western pharmaceuticals like those associated with Merck.Also in this story
- An NDA was granted for an oncology drug for use in the Chinese market.
- Summit Therapeutics presented data on a cancer drug targeting the immune system at the ASCO conference in Chicago.
The entities involved
-
LG Chem
South Korean chemical company